Profile

Stephen B. Tatter, M.D., Ph.D.Wake Forest Baptist Health

Doctor Rating

4.8 out of 5

238 Ratings
32 Comments
 

Stephen B. Tatter, M.D., Ph.D.

Professor,

Clinical Interests

Parkinson's Disease, Neurosurgery, Brain Tumors, Pituitary Tumors, Gamma Knife, Tremor

Contact Information

Department: 336-716-4081

Insurance Accepted »

Media Medical Expert »

Related Links

Education & Training

  • B.S., University of Michigan/Ann Arbor, 1982
  • M.D., Cornell University Medical College, 1990
  • Ph.D., Rockefeller University, 1990
  • Residency, Surgery, Massachusetts Gen Hosp, 1996
  • Fellowship, Harvard Medical School, 1997

Board Certifications

  • American Board of Neurological Surgery, Neurological Surgery

NPI Number

  • 1831178151
Stephen B. Tatter, M.D., Ph.D.

Doctor Rating

4.8 out of 5

238 Ratings
32 Comments
 

Stephen B. Tatter, M.D., Ph.D.

Professor, Neurosurgery

Research Interests

Radiosurgery; Brain Neoplasms; Neoplasm Recurrence, Local; Trigeminal Neuralgia; Meningioma
More »

Contact Information

Academic: 336-716-4047 | Department: 336-716-4081

Media Medical Expert »

Related Links

Recent Publications

Short pauses in thalamic deep brain stimulation promote tremor and neuronal bursting. Swan BD, Brocker DT, Hilliard JD, Tatter SB, Gross RE, Turner DA, Grill WM.. Clin Neurophysiol. 2016;127(2):1551-1559.

Ameliorating spinal cord injury in an animal model with mechanical tissue resuscitation. Zheng ZL, Morykwas MJ, Tatter S, Gordon S, McGee M, Green H, Argenta LC.. Neurosurgery. 2016;78(6):868-876.

Subsecond dopamine fluctuations in human striatum encode superposed error signals about actual and counterfactual reward. Kishida KT, Saez I, Lohrenz T, Witcher MR, Laxton AW, Tatter SB, White JP, Ellis TL, Phillips PE, Montague PR... Proc Natl Acad Sci U S A. 2016;113(1):200-205.

Association between subthalamic nucleus deep brain stimulation and weight gain: results of a case-control study. Strowd RE, Herco M, Passmore-Griffin L, Avery B, Haq I, Tatter SB, Tate J, Siddiqui MS.. Clin Neurol Neurosurg. 2016;140():38-42.

Emerging indications for fractionated gamma knife radiosurgery. McTyre E, Helis CA, Farris M, Wilkins L, Sloan D, Hinson WH, Bourland JD, Dezarn WA, Munley MT, Watabe K, Xing F, Laxton AW, Tatter SB, Chan MD.. Neurosurgery. 2016;():.

Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery. McKay WH, McTyre ER, Okoukoni C, Alphonse-Sullivan NK, Ruiz J, Munley MT, Qasem S, Lo HW, Xing F, Laxton AW, Tatter SB, Watabe K, Chan MD.. J Neurosurg. 2016;():.

Predictors of neurologic and nonneurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy. McTyre ER, Johnson AG, Ruiz J, Isom S, Lucas JT Jr, Hinson WH, Watabe K, Laxton AW, Tatter SB, Chan MD.. Neuro Oncol. 2016;():.

Brain metastasis velocity: a novel prognostic metric predictive of overall survival and freedom from whole-brain radiation therapy after upfront radiosurgery alone for brain metastases [abstract]. Farris M, McTyre E, Hughes RT, Ayala-Peacock DN, Randolph DM II, Bourland JD, Tatter SB, Laxton AW, Watabe K, Ruiz J, Li W, Zhou X, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):S180.

Genomic predictors of imaging response and survival in glioblastoma [abstract]. Soike M, McTyre E, Holmes JA, Paulsson AK, Miller L, Lesser GJ, Strowd RE, Johnson A, Lo HW, Laxton AW, Tatter SB, Debinski W, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):E121-E122.

Tumor resection with carmustine wafer placement as salvage therapy after local failure of radiosurgery for brain metastasis. Mu F, Lucas JT Jr, Watts JM, Johnson AJ, Daniel Bourland J, Laxton AW, Chan MD, Tatter SB.. J Clin Neurosci. 2015;22(3):561-565.

Gamma Knife radiosurgery for meningiomas in patients with neurofibromatosis Type 2. Liu A, Kuhn EN, Lucas JT Jr, Laxton AW, Tatter SB, Chan MD.. J Neurosurg. 2015;122(3):536-542.

Anaplastic ganglioglioma: a report of three cases and review of the literature. Lucas JT Jr, Huang AJ, Mott RT, Lesser GJ, Tatter SB, Chan MD.. J Neurooncol. 2015;123(1):171-177.

Competing risk analysis of neurologic versus nonneurologic death in patients undergoing radiosurgical salvage after whole-brain radiation therapy failure: who actually dies of their brain metastases?. Lucas JT Jr, Colmer HG IV, White L, Fitzgerald N, Isom S, Bourland JD, Laxton AW, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2015;92(5):1008-1015.

Neurosurgical management of brain metastases. Rodriguez A, Tatter SB.. Curr Probl Cancer. 2015;39(2):89-98.

Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases. Johnson AG, Ruiz J, Hughes R, Page BR, Isom S, Lucas JT, McTyre ER, Houseknecht KW, Ayala-Peacock DN, Bourland DJ, Hinson WH, Laxton AW, Tatter SB, Debinski W, Watabe K, Chan MD.. Oncotarget. 2015;6(22):18945-55.

Neurosurgical techniques for disruption of the blood-brain barrier for glioblastoma treatment. Rodriguez A, Tatter SB, Debinski W.. Pharmaceutics. 2015;7(3):175-187.

Repeat radiosurgery for trigeminal neuralgia. Helis CA, Lucas JT Jr, Bourland JD, Chan MD, Tatter SB, Laxton AW.. Neurosurgery. 2015;77(5):755-761.

Immunologic response to high-dose influenza vaccination in patients with primary central nervous system malignancy (PCNSM) [abstract]. Strowd RE, Russell G, Harmon M, Carter AF, Chan MD, Tatter SB, Laxton AW, High K, Lesser G.. J Clin Oncol. 2015;33(15 Suppl):e20669.

Factors that determine local control with gamma knife radiosurgery: the role of primary histology. Black PJ, Page BR, Lucas JT Jr, Hughes RT, Laxton AW, Tatter SB, Munley MT, Chan MD.. J Radiosurg SBRT. 2015;3(4):281-286.

Genomic predictors of patterns of progression in glioblastoma and possible influences on radiation field design. Holmes JA, Paulsson AK, Page BR, Miller LD, Liu W, Xu J, Hinson WH, Lesser GJ, Laxton AW, Tatter SB, Debinski W, Chan MD.. J Neurooncol. 2015;124(3):447-453.

A multi-institutional analysis of patients treated with stereotactic radiosurgery for brain metastases from radioresistant histologies [abstract]. Smith CA, McTyre E, Isom S, Kennedy VE, Luo G, Morales-Paliza M, Hinson W, Cmelak AJ, Tatter SB, Chan MD, Attia A.. Int J Radiat Oncol Biol Phys. 2015;93(3):E87-E88.

A competing risks analysis assessing predictors of neurologic and non-neurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy [abstract]. McTyre E, Johnson A, Ruiz J, Isom S, Lucas JT Jr, Hinson W, Watabe K, Laxton AW, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):S176.

Outcomes for anaplastic glioma treated with radiation therapy with or without concurrent temozolomide [abstract]. McTyre E, Lucas JT Jr, Helis C, Farris M, Houseknecht K, Mott R, Laxton AW, Tatter SB, Lesser GJ, Chan MD.. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):E108.

Impact of socioeconomic status on brain metastasis outcomes at a large academic radiosurgery center [abstract]. Houseknecht K, Taksler GB, Johnson A, Page BR, Hinson W, Laxton AW, Tatter SB, Weaver KE, Chan MD, Ruiz J.. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):E366.

Definitive treatment of vein of Galen aneurysmal malformation with stereotactic radiosurgery. Triffo WJ, Bourland JD, Couture DE, McMullen KP, Tatter SB, Morris PP.. J Neurosurg. 2014;120(1):120-125.

Clinical and economic outcomes of patients with brain metastases based on symptoms: an argument for routine brain screening of those treated with upfront radiosurgery. Lester SC, Taksler GB, Kuremsky JG, Lucas JT Jr, Ayala-Peacock DN, Randolph DM II, Bourland JD, Laxton AW, Tatter SB, Chan MD.. Cancer. 2014;120(3):433-441.

Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity?. Kilburn JM, Ellis TL [deceased], Lovato JF, Urbanic JJ, Bourland JD, Munley MT, Deguzman AF, McMullen KP, Shaw EG, Tatter SB, Chan MD.. J Neurooncol. 2014;117(1):167-174.

Single-institution retrospective series of gamma knife radiosurgery in the treatment of multiple sclerosis-related trigeminal neuralgia: factors that predict efficacy. Weller M, Marshall K, Lovato JF, Bourland JD, deGuzman AF, Munley MT, Shaw EG, Tatter SB, Chan MD.. Stereotact Funct Neurosurg. 2014;92(1):53-58.

Predictive nomogram for the durability of pain relief from gamma knife radiation surgery in the treatment of trigeminal neuralgia. Lucas JT Jr, Nida AM, Isom S, Marshall K, Bourland JD, Laxton AW, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2014;89(1):120-126.

Limited margins using modern radiotherapy techniques does not increase marginal failure rate of glioblastoma. Paulsson AK, McMullen KP, Peiffer AM, Hinson WH, Kearns WT, Johnson AJ, Lesser GJ, Ellis TL, Tatter SB, Debinski W, Shaw EG, Chan MD.. Am J Clin Oncol. 2014;37(2):177-181.

Influenza vaccine immunogenicity in patients with primary central nervous system malignancy. Strowd RE, Swett K, Harmon M, Carter AF, Pop-Vicas A, Chan M, Tatter SB, Ellis T [deceased], Blevins M, High K, Lesser GJ.. Neuro Oncol. 2014;16(12):1639-1644.

Mechanical tissue resuscitation at the site of traumatic brain injuries reduces the volume of injury and hemorrhage in a swine model. Zheng ZL, Morykwas M, Campbell D, McGee M, Hollingsworth C, Adams F, Mays J, Tatter S, Argenta L.. Neurosurgery. 2014;75(2):152-162.

A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy. Ayala-Peacock DN, Peiffer AM, Lucas JT, Isom S, Kuremsky JG, Urbanic JJ, Bourland JD, Laxton AW, Tatter SB, Shaw EG, Chan MD.. Neuro Oncol. 2014;16(9):1283-1288.

Predictors of survival, neurologic death, local failure, and distant failure after gamma knife radiosurgery for melanoma brain metastases. Neal MT, Chan MD, Lucas JT Jr, Loganathan A, Dillingham C, Pan E, Stewart JH IV, Bourland JD, Shaw EG, Tatter SB, Ellis TL.. World Neurosurg. 2014;82(6):1250-1255.

Neuronal oscillations in Parkinson's disease. Witcher M, Moran R, Tatter SB, Laxton AW.. Front Biosci (Landmark Ed). 2014;19():1291-1299.

Comparison of clinical outcomes and genomic characteristics of single focus and multifocal glioblastoma. Paulsson AK, Holmes JA, Peiffer AM, Miller LD, Liu W, Xu J, Hinson WH, Lesser GJ, Laxton AW, Tatter SB, Debinski W, Chan MD.. J Neurooncol. 2014;119(2):429-435.

Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery. Huang AJ, Huang KE, Page BR, Ayala-Peacock DN, Lucas JT Jr, Lesser GJ, Laxton AW, Tatter SB, Chan MD.. J Neurooncol. 2014;120(1):163-169.

Is there a tumor volume threshold for postradiosurgical symptoms? A single-institution analysis. Kuhn EN, Taksler GB, Dayton O, Loganathan A, Bourland D, Tatter SB, Laxton AW, Chan MD.. Neurosurgery. 2014;75(5):536-545.

Leptomeningeal failure in patients with breast cancer receiving stereotactic radiosurgery for brain metastases [abstract]. Page BR, Huang AJ, Huang KE, Laxton AW, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S245.

Does delay of start of radiation affect clinical outcomes of glioblastoma [abstract]. Randolph DM, Peiffer AM, Paulsson AK, Hinson W, Laxton AW, Tatter SB, Debinski W, Chan MD.. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S295.

Genomic predictors of infield and marginal failure for glioblastoma treated with concurrent radiation therapy and temozolomide: a step towards personalized radiation fields? [abstract]. Holmes JA, Paulsson A, Peiffer AM, Miller LD, Xu J, Hinson WH, Lesser GJ, Tatter SB, Debinski W, Chan MD.. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S291-S292.

A propensity score adjusted analysis of patients receiving up-front SRS versus WBRT: does the use of upfront WBRT really affect neurologic death? [abstract]. Lucas JT, Ayala-Peacock DN, Piazza M, Kuremsky JG, Page BR, Randolph D, Fitzgerald N, Holmes JA, Soike M, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S315-S316.

Functional presence of M2 macrophage markers in GBM tumor cells [abstract]. Debinski W, Rodriguez A, Gibo D, Tatter SB, Mott R, Lively M, Miller L, Seals DF.. Neuro Oncol. 2014;16(Suppl 3):.

Multisurgeon, multisite validation of a trajectory planning algorithm for deep brain stimulation procedures. Liu Y, Konrad PE, Neimat JS, Tatter SB, Yu H, Datteri RD, Landman BA, Noble JH, Pallavaram S, Dawant BM, D'Haese PF.. IEEE Trans Biomed Eng. 2014;61(9):2479-2487.

The role of laser interstitial thermal therapy in enhancing progression-free survival of difficult-to-access high-grade gliomas: a multicenter study. Mohammadi AM, Hawasli AH, Rodriguez A, Schroeder JL, Laxton AW, Elson P, Tatter SB, Barnett GH, Leuthardt EC.. Cancer Med. 2014;3(4):971-979.

A pilot study of high-dose influenza vaccine immunogenicity in patients with primary central nervous system malignancy [abstract]. Strowd R, Russell G, Harmon M, Carter A, Chan M, Tatter S, Laxton A, High K, Lesser G.. Neuro Oncol. 2014;16(Suppl 5):v207.

Improved efficacy of temporally non-regular deep brain stimulation in Parkinson's disease. Brocker DT, Swan BD, Turner DA, Gross RE, Tatter SB, Koop MM, Bronte-Stewart H, Grill WM.. Exp Neurol. 2013;239():60-67.

Neuroanatomical target theory as a predictive model for radiation-induced cognitive decline. Peiffer AM, Leyrer CM, Greene-Schloesser DM, Shing E, Kearns WT, Hinson WH, Tatter SB, Ip EH, Rapp SR, Robbins ME [deceased], Shaw EG, Chan MD.. Neurology. 2013;80(8):747-753.

Vacuum-assisted closure for complex cranial wounds involving the loss of dura mater. Powers AK, Neal MT, Argenta LC, Wilson JA, DeFranzo AJ, Tatter SB.. J Neurosurg. 2013;118(2):302-308.

Radiosurgical management of trigeminal neuralgia. Chan MD, Shaw EG, Tatter SB.. Neurosurg Clin N Am. 2013;24(4):613-621.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Neurosurgery

Clinical Interests

Parkinson's Disease, Neurosurgery, Brain Tumors, Pituitary Tumors, Gamma Knife, Tremor
Stephen B. Tatter, M.D., Ph.D.

Stephen B. Tatter, M.D., Ph.D.

Professor, Neurosurgery

Doctor Rating

4.8 out of 5

Stephen B. Tatter, M.D., Ph.D.238 Ratings
32 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.9
CP efforts to include in decisions
4.9
CP explanations of prob/condition
4.9
CP spoke using clear language
4.9
Friendliness/courtesy of CP
4.9
Likelihood of recommending CP
4.9
Patients' confidence in CP
4.9
Time CP spent with patient
4.8
Wait time at clinic
4.2



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

10/19/2016

*Dr. Tatter has all qualities of a SUPERB EXCELLENT physician!

10/19/2016

I know that I am in the best hands with God and *Steve Tatter MD.

10/11/2016

This appointment was a follow up to a surgery that happened 3 1/2 years ago. This provider is only addressing that. I am satisfied with the care I am receiving as a result of that surgery.

9/29/2016

I can't say enough good things about the patient care experience @ Wake Forest. *Dr. Tatter, *Rich and his team are tops. I work in healthcare & know this is an exceptional office!

9/19/2016

I valued Dr Tatter's opinion and his staff.

9/17/2016

Dr. Tatter has always treated me well.

8/31/2016

Dr. Tatter was the VERY best, couldn't have asked for better.

8/29/2016

I am very glad that my first Neurologist at UNC recommended Dr. Tatter at Wake Forest including Dr. Chan. The reoccurrance of the meningioma was unsettling to me and my family. Dr. Tatter took his time to explain why the reoccurrance of the tumor and the most likely cause. The explanation of each choice I had was also explained very well so I could make a well informed decision. I feel that the care I received from all of the staff and Dr.Tatter himself was beyond exceptional. I am glad the care I received is equivalent if not above that of Brigham and Women's Hospital in Boston, MA.

8/28/2016

Dr. Tatter is extremely knowledgable. He takes time to share similar scenarios to ease my concerns.

8/25/2016

No bad experience. Have already recommended to others.

8/24/2016

Great experience.

8/18/2016

Will highly recommend Dr. Tatter and his staff.

8/8/2016

Great physician however does not respect pt's time always late for appt's.

8/1/2016

His knowledge & thoroughness of care has resulted in a successful recovery. WFBH is lucky to have such a skilled and professional surgeon on staff w/*Dr. Tatter!

6/2/2016

*Dr. Tatter is an attentive listener. He answered all of my questions.

5/22/2016

my experience with the doctor was very good.

5/10/2016

Dr. Tatter is beyond awesome

5/2/2016

First time meeting *Dr. Tatter - very courteous and compassionate doctor!!

4/13/2016

I would highly recommend Dr. Tatter, and everyone else we talked with described him as wonderful. I thought maybe 'wonderful' was his middle name

3/2/2016

*Tatter was very personable.

2/27/2016

Excellent care throughout the surgical process.

2/17/2016

good

2/15/2016

I really feel Dr. Tatter saved my life by keeping me out of surgery. I wish I been referred to him when I was first diagnosed with chiari malformation and probably would have been able to avoid my first brain surgery. My life would be so different right now. The professionalism of Wake Forest is amazing as so is Dr. Tatter. I chose both over Duke Hospital and Dr. Alan Friedman, and I am so thankful I did everyday.

2/5/2016

Good.

2/5/2016

Could not ask for better care from doctor and his physician ass't.!

1/27/2016

Excellent surgeon.

1/19/2016

Was my first time seeing Dr. Tatter and his staff. I am a former patient for Dr. Thomas Ellis and this was a routine check up. I have nothing but wonderful things to say Dr. Tatter and his staff.

1/12/2016

Good.

12/28/2015

Dr Tatter is top notch!! I am retired US Army and if it were up to me he would be a General in his field! I cannot say enough good about him!

12/21/2015

*Dr. Tatter is ABSOLUTELY SUPERB - knowledgeable, friendly, professional, caring a blessing to his pts. *DR. TATTER

12/16/2015

Dr. Tatter is very thorough and has a wonderful bedside manner. He takes time to fully discuss my prognosis and next steps. He very thoughtfully considers the best strategy for my care and discusses those options with me. I have no hesitation in recommending him to family and friends and often do.

12/15/2015

Would highly recommend him.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.